NCT00622765 A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients Status COMPLETED Phase PHASE2
NCT00607373 Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT00550706 Drug Utilization Prevalence in a Pediatric Care Medical Center Status COMPLETED Phase N/A
NCT00477594 Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia Status COMPLETED Phase PHASE2
NCT00446264 Islet Allotransplantation With Steroid Free Immunosuppression Status COMPLETED Phase PHASE2
NCT00387114 Effect of an Anti-Oxidant Treatment on Resistin Serum Levels.A Randomized Study Status TERMINATED Phase PHASE3
NCT00362180 Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration Status COMPLETED Phase PHASE2
NCT00192621 Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects Status COMPLETED Phase PHASE4
NCT00129792 Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome Status COMPLETED Phase NA
NCT00119405 Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Status COMPLETED Phase N/A
NCT00119379 Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults Status COMPLETED Phase PHASE2